Genetic marker method for diabetic retinopathy wins patent

Waltham, MA-Interleukin Genetics Inc. has received a U.S. patent for a method that uses specific genetic markers to identify people with diabetes who are at an increased risk of retinopathy.

Related Videos
View All
Related Content
© 2023 MJH Life Sciences

All rights reserved.